Corporate Banner
Satellite Banner
Technology Networks Header
Monday, November 24, 2014
Technology Networks
 
Register | Sign in
Home Page > Videos > Improvements in Molecular Diagnosis of Pathogens and Diseases
  Videos

Return

Improvements in Molecular Diagnosis of Pathogens and Diseases
SELECTBIO

Loop-mediated Isothermal Amplification (LAMP) belongs to a range of main current and new diagnostic techniques for early-stage detection of pathogens such as viruses, bacteria, fungi, protozoa, worms, amongst other. In addition, molecular recognition of cancer, genetic disorders and species determination or sex determination of organisms has also achieved by LAMP. The LAMP reaction was found to be superior over the Polymerase Chain Reaction (PCR) in most cases with respect to detection limit, sensitivity, specificity and usefulness. The superior capability of LAMP relies on the application of primer sets consisting of four to six designated primers that recognize certain regions of the target nucleic acid sequence and on the incorporation of Bst DNA polymerase capable of splicing DNA strands. We can expect that research on and application of the LAMP method will take a course that is similar to that of the PCR method during the last decades, which means improvement of its already high sensitivity and specificity, improvement of its multiplexing capability, extension of its application fields to both highly specialized detection tasks and fields of economic interest and further cost reduction. This presentation will offer a valuable guide to the development of LAMP in molecular detection and determination of target sequences and will present examples with bright field applications of the method from the detection of pathogens to clinical applications for the diagnosis of cancer and other disorders according to current stage of this well-accepted methodology by the scientific community during the last decade.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Precisely Off The Mark
Possible cause discovered for failure of targeted liver cancer therapies.
Novel Cancer Vaccine Approach for Brain Tumors
Researchers unravel the mechanisms behind a novel cancer vaccine for brain tumors, paving the way for further development.
New Test Developed at Dana-Farber/Brigham and Women's Cancer Center
Rapid Heme Panel - A high-tech genetic test that speeds treatment decisions for blood cancer patients.
Researchers Silence Leading Cancer-Causing Gene
A novel siRNA-based molecule successfully targets KRAS, a well-studied but hard to halt protein important for cancer development and metastasis.
Tumor Suppressor Also Inhibits Key Property Of Stem Cells
The retinoblastoma protein inhibits cancer by controlling cell division. Now, researchers have shown that it also binds to and inhibits genes necessary for pluripotency.
Almac Announces Launch of CLIA Validated Next Generation Sequencing Assay
P53 considered important biomarker for cancer drug discovery.
Next-Gen Melanoma Drug Excels in Lab Tests
Anti-cancer activity was reported in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733.
Study Identifying Cell of Origin for Large, Disfiguring Nerve Tumors
Lays groundwork for development of new therapies.
Light Shed On Genetic Architecture Of Kidney Cancer
Research reveals link between renal cell carcinoma and exposure to aristolochic acid.
Salk Scientists Discover a Key to Mending Broken Hearts
Researchers regenerate and heal mouse hearts by using the molecular machinery the animals had all along.
Scroll Up
Scroll Down
SELECTBIO
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv